Opsoclonus-Myoclonus Syndrome in Children and Adolescents: A Therapeutic Challenge
Opsoclonus-myoclonus syndrome (OMS) is a neurological non-fatal disease that usually responds to immunotherapies. However, the real challenge is to counteract the high frequency of relapses and long-term developmental sequelae. Since the OMS is extremely rare, a common consensus regarding therapeuti...
Guardado en:
Autores principales: | Marina Auconi, Laura Papetti, Claudia Ruscitto, Michela Ada Noris Ferilli, Fabiana Ursitti, Giorgia Sforza, Federico Vigevano, Massimiliano Valeriani |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a339353d51e94e9a8289d93d2cec185c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Breast cancer-associated opsoclonus-myoclonus syndrome: a case report
por: Aikaterini Kostoglou, et al.
Publicado: (2021) -
Multifocal myoclonus as a presentation of levetiracetam toxicity
por: Mei Bou Nasif, et al.
Publicado: (2021) -
Neuropsychological Sequelae, Quality of Life and Adaptive Behavior in Children and Adolescents with Anti-NMDAR Encephalitis: A Narrative Review
por: Samuela Tarantino, et al.
Publicado: (2021) -
Clinical Characteristics and Outcomes of Children With Extracorporeal Membrane Oxygenation in a Developing Country: An 11-Year Single-Center Experience
por: Wirapatra Iamwat, et al.
Publicado: (2021) -
Evaluating the Functional Outcomes and the Quality of Life for Pediatric Patients with Osteogenesis Imperfecta after Fracture Treatment with Intramedullary Rodding
por: Alexandru Herdea, et al.
Publicado: (2021)